Behind the scenes

what

AIDA aims to develop and validate a multidisciplinary AI-powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric-inflammation and suggesting personalised therapeutics and monitoring.

how

We envision a new form of collaboration, beyond the public-private partnership model, in which participants from different countries or sectors exchange their data to create public value.

Data collaboratives form a sustainable answer to the problem that collaborative research and clinical innovation are generally limited to local, fragmented of limited quality, and research is progressing through ad-hoc collaborations on specific projects.

why

The Sooner. The Better.

Most cases of gastric cancer are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing gastric cancer at the pre-symptomatic stage, typically chronic infection with H. pylori, could significantly improve the outlook.

Spread the word!

In order to make our research accessible to everyone, you can easily download a free documentation of AIDA. No registration needed.

what

AIDA related news

en

AIDA General Assembly 2026

The AIDA consortium gathered in Genova, Italy, on April 21 & 22, 2026, for the annual General Assembly Meeting, bringing together researchers, clinicians, AI experts, and patient representatives from across Europe to review progress and discuss the next steps of